Science News & Science Current Events
 

Therapeutic Cloning Current Events | Therapeutic Cloning News | 5
Page 5 of 14 | 328 Results
Previous0102030405060708091011   Next   
Sort By: Page Views | Date
Questions over 'healing effect' of magnet therapy
Patients should be advised that magnet therapy has no proved benefits, and that any healing effect is likely to be small, say US researchers in this week's BMJ.   view more (2006-01-06)

Infliximab Could Prevent Sight Loss From Behcet's Disease (p 295)
A drug used to treat rheumatoid arthritis and Crohn's disease could play an important role in preventing sight loss associated with the inflammatory disorder Behcet's disease, suggest authors of a fast-track research letter published in this week's issue of THE LANCET. Beh'§et's disease is a rare... view more (2001-07-25)

UWE Research team advise Royal Society on Science Communication
The Graphic Science team in the Faculty of Applied Sciences at the University of the West of England has won a £10,000 contract from the Royal Society of London. The Society has just received a large donation from the Kohn Foundation that will enable it to run an enhanced Science and Society... view more (2001-01-16)

HIV vaccine takes different tack to boosting immune response
esearchers at Baylor College of Medicine (BCM) in Houston have reason to believe their unorthodox vaccine could one day help to prevent or control HIV infection.   view more (2006-01-03)

Professor Claude Héle'ne will be chairing UroGene`s Scientific Advisory Board
UroGene S.A. (Evry Génopole - France), is a biopharmaceutical company specialised in the development of new drugs in the field of urological cancers (prostate, kidney, bladder). The company is announcing that Professor Claude Héle'ne has undertaken the task of chairing their... view more (2002-03-21)

Interesting lead in the treatment of Ewing`s sarcoma
Research scientists at INSERM, CNRS and the Institut Curie, in collaboration with physicians, have used a mouse model to demonstrate the efficacy of an innovative therapeutic approach to Ewing`s sarcoma: the combination of human interferon (alpha or beta) and a common anti-tumor agent, ifosfamide.... view more (2002-10-31)

Advances in HBV DNA assays are key to determine best long-term treatment strategies for Hepatitis B
For the 350 million people chronically infected with HBV, the two therapeutic approaches currently available are immunomodulatory agents and antiviral chemotherapy. The first therapeutic agent was interferon-alpha (IFN-alpha), whose dual mode of action includes both antiviral and immunomodulatory... view more (2005-01-10)

Medical Use for New Sugar Coated Proteins
Making sugar coated proteins for use in medicines is a step closer thanks to a chance discovery by scientists from the London School of Hygiene and Tropical Medicine. The research is presented today, Tuesday 9 September 2003, by Professor Brendan Wren at the Society for General Microbiology’s... view more (2003-08-27)

The Institut Curie and Hybrigenics receive 2.4 million euros from the Ministry of Industry for the GenHomme research and technological innovation network
Nicole Fontaine, the minister for industry, will today officially award a subsidy to the functional proteomics company Hybrigenics and to the Institut Curie, a center dedicated to cancer research and treatment. Nicole Fontaine thus declares her conviction that the strengthening of the synergy... view more (2003-03-19)

Study suggests new treatments for Huntington's disease
Working with fruit flies, researchers have discovered a new mechanism by which the abnormal protein in Huntington's disease causes neurodegeneration.   view more (2008-01-10)

Smokeless cannabis delivery device efficient and less toxic
A smokeless cannabis-vaporizing device delivers the same level of active therapeutic chemical and produces the same biological effect as smoking cannabis, but without the harmful toxins, according to UCSF researchers.   view more (2007-05-16)

Mayo Clinic researchers invent 'hitchhiking' viruses as cancer drug delivery system
A Mayo Clinic research team has devised a new virus-based gene therapy delivery system to help fight cancer. Researchers say their findings will help overcome hurdles that have hindered gene therapy cancer treatments.   view more (2005-09-19)

An effective strategy for inhibition of cirrhosis
In China, the incidence of liver cirrhosis is still high, although new therapeutic approaches have recently been proposed, there is no established therapy for liver fibrosis, and Authors investigated the prevention effects of Chinese Medicine Qianggan-Rongxian Soup on liver fibrosis induced by DMN... view more (2008-09-25)

Mayo Clinic researchers enhance safety and effectiveness of therapeutic virus that fights cancer
Mayo Clinic researchers working with colleagues in Germany have devised a much-needed multilevel safety feature for viruses used to treat cancer.   view more (2006-08-01)

Alzheimer's disease prevention may be easier than cure
Current hypotheses suggest that it is the accumulation over time of amyloid beta peptide 1-42 (Abeta42) that triggers changes in the brain that lead to cognitive dysfunction in Alzheimer's disease.   view more (2005-12-09)

Breathing Support Reduces Blood Pressure For People With Sleep Apnoea (p 204)
A reduction in blood pressure-and in the probable risk of stroke and other cardiovascular disease-could be possible for patients treated with nocturnal breathing support for sleep apnoea, conclude authors of a study in this week's issue of THE LANCET. Obstructive sleep apnoea is a serious condition... view more (2002-01-17)

Viagra®, unlikely tool for vision research, slows the visual response to flickering light
Therapeutic doses of Viagra¬Æ have been shown to influence the rate at which visual signals are integrated by the brain, affecting the way quick, repeated events, such as flickering light, are perceived.   view more (2006-01-24)

Penn bioethicst challenges scientists to lead the public in discussions about their work
In the first-ever article on bioethics to appear in Cell, one of the nation's leading bioethicists challenges scientists to proactively engage the public in discussions about the value and significance of their research protocols to maintain an ethical base, at all times, in the conduct of their... view more (2006-06-16)

Carnegie Mellon researcher proposes development of artificial cells to fight disease
Carnegie Mellon University's Philip LeDuc predicts the use of artificially created cells could be a potential new therapeutic approach for treating diseases in an ever-changing world.   view more (2007-02-08)

New U of T strategy will boost cord blood stem cells
A team of bioengineers led by the University of Toronto has discovered a way to increase the yield of stem cells from umbilical cord blood, to an extent which could broaden therapeutic use of these cells.   view more (2005-10-19)

Ewing's sarcoma : Discovery of a "link" in tumor growth
To develop new therapeutic approaches to cancer, it is essential to understand the long and extremely complex process that underlies it, in other words the various stages of cancer development from the initial mutation to the tumor. Having already identified the alteration that leads to Ewing's... view more (2004-09-23)

Newly Identified Gene Activated In 80% Of Breast Cancer Patients
New research, published this week in Breast Cancer Research, could provide a genetic explanation for breast cancer. A George Washington University Medical Center team, led by Patricia Berg, has discovered that the gene BP1 is activated in 80% of breast cancer patients. The researchers believe that... view more (2003-04-25)

New uses for endoscopy
Braquitherapy guided by ecoendoscopy has enabled a therapeutic approach to injuries, hitherto inaccessible by other means.   view more (2006-04-04)

Trial success for diabetic nerve therapy
A potentially ground-breaking treatment for nerve damage caused by diabetes has shown promising results in preclinical and early patient trials.   view more (2006-05-31)

Bare metal stents deliver gene therapy to heart vessels with less inflammation in animal studies
Improved materials may allow stents, tiny metal scaffolds inserted into blood vessels, to better deliver beneficial genes to patients with heart disease, by reducing the risk of inflammation that often negates initial benefits.   view more (2005-12-20)
Page 5 of 14 | 328 Results
Previous0102030405060708091011   Next   
Sort By: Page Views | Date
© 2008 BrightSurf.com